Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.
Achieved serum samples of the different testing groups are retrieved and tested with the immunoassays according to manufacturer's instruction.
The test results are then compared and analyzed with statistical tests to assess the immunoassays'performance
Inclusion criteria for COVID-19 infected sera: any patient with PCR confirmed COVID-19 infection
Inclusion criteria for COVID-19 negative sera: sera collected after a negative SARS-CoV-2 PCR
Exclusion Criteria:
-